MSB 3.21% $1.13 mesoblast limited

That's not how I read it at all, I read it that over the full...

  1. 77 Posts.
    lightbulb Created with Sketch. 1533
    That's not how I read it at all, I read it that over the full duration of the study they do not achieve a statistically significant result.

    At 24 months, THE PRIMARY END POINT:Treatment Success (composite responder analysis of low back pain Visual Analogue Scale (VAS) score, Oswestry Disability Index (ODI) score and no post-treatment interventions) [ Time Frame: 24 Months ]• To determine Overall Treatment Success of rexlemestrocel-L alone or rexlemestrocel-L+HA through 24 months based on a composite responder analysis

    They achieved a significant result reduction in pain:

    https://hotcopper.com.au/data/attachments/2894/2894558-c13d162214e73382771c8169d707565a.jpg
    I feel like I'm taking crazy pills lol

    @LeftYahoo am I totally missing something.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.